Detecting ventricular capture from atrial pacing by implantable device
By sensing and delivering cardiac pacemakers using the first and second electrodes in a pacemaker, processing circuits identify and adjust chamber capture, solving the difficulty of detecting and adjusting multi-chamber capture by prior art central pacemakers. The problem improves the accuracy and efficiency of treatment.
Patent Information
- Application Number
- CN202380030484.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-28
- Filing Date
- 2023-03-27
- Publication Date
- 2024-11-22
AI Technical Summary
Existing pacemakers are difficult to effectively detect and adjust multi-chamber cardiac capture, resulting in inefficiency in treatment.
A medical device for implantation of the heart is designed, including a first electrode and a second electrode, through which the electrical activity of the heart is sensed and cardiac pacing is delivered through a treatment delivery circuit, which is based on the electrical activity identification of the second chamber. Capture and adjust the pacing of the first chamber.
The detection and adjustment of multi-chamber capture of the heart is achieved, and the accuracy and efficiency of cardiac pacing treatment are improved.
Smart Images

Figure CN119013077A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to medical devices, and more particularly to medical devices that deliver cardiac pacing. Background Art
[0002] Various types of implantable medical devices (IMDs) have been implanted for treating or monitoring one or more conditions in a patient. Such IMDs may be suitable for monitoring or treating conditions related to the heart, muscles, nerves, brain, stomach, endocrine organs, or other organs and their associated functions. Such IMDs may be associated with leads that position electrodes at desired locations, or may be leadless, with electrodes integrated with and / or attached to the device housing. These IMDs may have the ability to wirelessly transmit data to another device implanted in the patient, another instrument positioned outside the patient's body, or both.
[0003] A pacemaker is a medical device, such as an IMD, that is configured to deliver cardiac pacing therapy to restore a more normal heart rhythm. A pacemaker senses the electrical activity of the heart and delivers cardiac pacing via electrodes based on the sensed electrical activity. Some pacemakers are implanted at a distance from the heart and are coupled to one or more leads that extend into the heart within a blood vessel to position the electrodes relative to the heart tissue. Some pacemakers are designed to be fully implanted in one of the chambers of the heart and may include electrodes that are integrated with or attached to the device housing instead of leads. Some pacemakers provide dual-chamber functionality by sensing and / or stimulating the activity of both the atria and ventricles, or provide other multi-chamber functionality. A pacemaker may provide multi-chamber functionality via leads extending to the corresponding heart chambers, multiple pacemakers may provide multi-chamber functionality by being implanted in the corresponding chambers, or a pacemaker implanted in one chamber may sense and pace multiple chambers. Summary of the invention
[0004] In general, the present disclosure relates to the operation of devices implanted within a single chamber of the heart, and to delivering cardiac pacing to more than one chamber of the heart. More specifically, the present disclosure relates to techniques that can be implemented by such devices to detect capture of ventricular tissue in response to cardiac pacing delivered to atrial tissue and to adjust cardiac therapy in response.
[0005] In one example, the present disclosure may be directed to a device comprising: a housing; a first electrode and a second electrode, wherein the first electrode is configured to contact tissue of a first chamber of a heart, and wherein the second electrode is configured to penetrate into tissue of a second chamber of the heart separate from the first chamber of the heart; a sensing circuit within the housing, wherein the sensing circuit is configured to sense electrical activity of the first chamber via the first electrode and to sense electrical activity of the second chamber via the second electrode; a therapy delivery circuit within the housing, wherein the therapy delivery circuit is configured to deliver cardiac pacing to the first chamber via the first electrode and to the second chamber via the second electrode; and a processing circuit within the housing. The processing circuit is configured to: identify capture of the tissue of the second chamber in response to delivery of cardiac pacing to the first chamber by the therapy delivery circuit via the first electrode based on the sensed electrical activity of the second chamber; and adjust the cardiac pacing to the first chamber based on the identification of the capture of the second chamber.
[0006] In another example, the present disclosure may relate to a method comprising delivering cardiac pacing from a device to a first chamber of a heart via a first electrode of the device; sensing electrical activity in a second chamber of the heart separated from the first chamber of the heart by the device and via a second electrode of the device penetrating into tissue of the second chamber; identifying capture of the tissue of the second chamber by the device and based on the sensed electrical activity of the second chamber in response to the delivery of cardiac pacing to the first chamber via the first electrode; and adjusting, by the device, the cardiac pacing to the first chamber performed by the therapy delivery circuit in response to the identification of the capture of the second chamber.
[0007] In another example, the present disclosure may relate to a method comprising delivering a test cardiac pacing pulse from a device to a first chamber of a heart via a first electrode of the device; detecting, by the device and via the first electrode of the device and a second electrode penetrating into tissue of a second chamber of the heart separate from the first chamber of the heart, respectively, electrical activity of the first chamber and the second chamber; determining, by the device and based on the sensed electrical activity of the first chamber, a capture threshold of the tissue of the first chamber; determining, by the device and based on the sensed electrical activity of the second chamber, a cross-chamber capture threshold of the tissue of the second chamber and a maximum pacing output for the first chamber; and transmitting, by the device and based on a comparison of the capture threshold with the maximum pacing output, to another device via a network an indication of adjusting the position of the first electrode within the first chamber.
[0008] In another example, the present disclosure may relate to a computer-readable storage medium including instructions that, when executed, cause a processing circuit within a device to perform the method described above.
[0009] This summary is intended to provide an overview of the subject matter described in this disclosure. This summary is not intended to provide an exclusive or exhaustive explanation of the methods and systems described in detail in the following figures and specification. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The details of one or more examples of the present disclosure are set forth in the following drawings and description. Other features, objects, and advantages of the present disclosure will be apparent from the description and drawings, as well as from the claims. With reference to the accompanying drawings, elements with the same reference numerals always represent similar elements.
[0011] Figure 1 is a conceptual diagram illustrating an exemplary device implanted in a patient's heart according to one or more aspects of the present disclosure.
[0012] Figure 2 The present invention is a method for illustrating one or more aspects of the present invention. Figure 1 A perspective view of an exemplary device.
[0013] Figure 3 The present invention is a method for illustrating one or more aspects of the present invention. Figure 1 and Figure 2 A functional block diagram of an exemplary configuration of an IMD.
[0014] Figure 4 It is implanted at the target implantation site Figures 1 to 3 Conceptual image of the device.
[0015] Figure 5 is a block diagram illustrating an exemplary configuration of the computing device 120 .
[0016] Figure 6 is a graph of an exemplary electrogram (EGM) graph showing normal atrial and ventricular activity.
[0017] Figure 7 is a graph of an exemplary EGM plot showing capture of a second chamber in response to delivery of an excitation signal to a first chamber.
[0018] Figure 8 is a flow chart illustrating an exemplary method for detecting capture of a second chamber in response to delivery of an excitation signal to a first chamber.
[0019] Fig. 9 is a flow chart illustrating an exemplary method for confirming detection of capture of a second chamber in response to delivery of an excitation signal to a first chamber.
[0020] Fig.10 is a flow chart illustrating an exemplary method for detecting capture of a second chamber in response to delivery of an excitation signal to a first chamber during implantation of an implantable medical device. DETAILED DESCRIPTION
[0021] In general, the present disclosure relates to medical devices such as implantable medical devices (IMDs) having a housing sized to be implanted entirely within a single chamber of the heart. More specifically, the present disclosure relates to techniques that can be implemented by such medical devices that allow for detection of capture of ventricular tissue in response to application of cardiac pacing therapy to atrial tissue. In some examples, in addition to detection of ventricular capture, systems and methods may also allow for adjustment of cardiac therapy in response to detection of ventricular capture.
[0022] In some cases, an IMD implanted entirely within a first chamber of the heart (e.g., in the right atrium) can deliver an excitation signal into the first chamber at a sufficiently high magnitude that the excitation signal travels into wall tissue of a second chamber of the heart (e.g., the right ventricle) and causes stimulation of the wall tissue of the second chamber (e.g., causing ventricular capture).
[0023] Figure 1 1 is a conceptual diagram illustrating an exemplary device 104 implanted in a patient's heart 100 according to one or more aspects of the present disclosure. The device 104 is shown implanted in a target implantation region 102 (such as the triangle of Koch in the patient's heart 100) in the right atrium (RA) of the patient's heart 100, with the distal end of the device 104 pointing toward the left ventricle (LV) of the patient's heart 100. Figure 1 In the example of the present invention, the distal end of the device 104 is directed toward the LV, but in some examples, the distal end can be directed toward other targets, such as the interventricular septum of the heart 100. The target implantation area 102 can be located between the bundle of His and the coronary sinus, and can be adjacent to the tricuspid valve. In other examples, the device 104 can be implanted in the left atrium (LA) with the distal end of the device 104 directed toward the right ventricle (RV).
[0024] The device 104 includes a distal end 108 and a proximal end 110. The distal end 108 includes a first electrode 114 and a second electrode 112. The second electrode 112 extends from the distal end 108 and can penetrate the wall tissue of the first cavity (e.g., RA in the illustrated example) into the wall tissue of the second cavity (e.g., LV in the illustrated example). The first electrode 114 extends from the distal end 108 and is configured to flexibly maintain contact with the wall tissue of the first cavity without the first electrode 114 penetrating the wall tissue of the first cavity. Figure 1 and Figure 2The configuration of electrodes 112 and 114 shown is merely an example. In general, the techniques of the present disclosure may be implemented by any device having one or more electrodes configured to pace and sense the ventricles, such as by penetrating myocardial tissue, and one or more electrodes configured to pace and sense the atria, such as by contacting tissue.
[0025] Figure 1 The configuration of electrodes 112 and 114 shown allows device 104 to sense cardiac signals and / or deliver cardiac pacing to multiple chambers of heart 100 (e.g., RA and ventricle in the example shown). In this manner, the configuration of electrodes 112 and 114 can facilitate delivery of AV synchronized pacing by a single device 104 implanted in a single chamber (e.g., RA). Figure 1 In the example shown, the device 104 is implanted at the target implant region 102 to sense and / or pace the RA and ventricles, but the device having an electrode configuration according to the examples of the present disclosure may be implanted at any of a variety of locations to sense and / or pace any two or more chambers of the heart 12. For example, the device 104 may be implanted at the region 102 or another region, and the second electrode 112 may extend into tissue of the LV or ventricular septum (e.g., myocardial tissue) to, for example, facilitate the delivery of AV synchronized pacing. In addition, the device having an electrode configuration according to the examples of the present disclosure may be implanted at any of a variety of locations in the patient's body for sensing and / or delivering therapy to other patient tissues.
[0026] Figure 1 Also shown is a computing device 120, which may be part of a medical device system with device 104. Computing device 120 may be an external device configured to wirelessly communicate with device 104, for example to retrieve data from device 104, including any data described herein. In some examples, computing device 120 may include a user interface to present the retrieved data to a user, such as a patient or clinician. In some examples, computing device 120 may be programmable to control parameters of the operation of device 104, such as cardiac pacing parameters or sensing parameters.
[0027] Figure 2 is a perspective view showing the device 104. The device 104 includes a housing 200 that defines a hermetically sealed internal cavity. The housing 200 can be formed of a conductive material, including titanium or a titanium alloy, stainless steel, MP35N (non-magnetic nickel-cobalt-chromium-molybdenum alloy), a platinum alloy or other biocompatible material or metal alloy, or other suitable conductive material. In some examples, the housing 200 is formed of a non-conductive material, including ceramic, glass, sapphire, silicone, polyurethane, epoxy resin, acetyl copolymer plastic, polyetheretherketone (PEEK), liquid crystal polymer, other biocompatible polymers, or other suitable non-conductive materials.
[0028] The housing 200 extends from a distal end 202 and a proximal end 204. In some examples, the housing can be cylindrical or substantially cylindrical, but can also be other shapes, such as prismatic or other geometric shapes. The housing 200 can include, for example, a delivery tool interface member 206 located at the proximal end 204 for engaging with a delivery tool during implantation of the device 104.
[0029] During pacing and / or sensing, all or substantially all or a portion of housing 200 may be used as electrode 208, such as an anode. In some examples, electrode 208 may surround a portion of housing 200 at or near proximal end 204. Electrode 208 may completely or partially surround housing 200. Figure 2 The electrode 208 is shown extending as a single strip. The electrode 208 may also include multiple segments spaced a distance apart along the longitudinal axis 210 of the housing 200 and / or around the perimeter of the housing 200.
[0030] When the housing 200 is formed of a conductive material such as a titanium alloy, portions of the housing 200 may be electrically insulated by a coating of a non-conductive material such as parylene, polyurethane, silicone, epoxy or other biocompatible polymer or other suitable material. For portions of the housing 200 that do not have a non-conductive material, one or more discrete areas of the housing 200 having a conductive material may be exposed to define electrodes 208.
[0031] When housing 200 is formed of a non-conductive material (such as ceramic, glass or polymer material), a conductive coating or layer (such as titanium, platinum, stainless steel, alloys thereof), a conductive material may be applied to one or more discrete areas of housing 200 to form electrodes 208.
[0032] In some examples, the electrode 208 can be a component mounted or assembled to the housing 200, such as a ring electrode. When the housing 200 is a non-conductive material, the electrode 208 can be electrically coupled to the internal circuit of the device 104 via the conductive housing 200 or the electrical conductor. In some examples, the electrode 208 is located near the proximal end 204 of the housing 200 and can be referred to as a proximal housing-based electrode. The electrode 208 can also be located at other locations along the housing 200, such as near the distal end 202 or at other locations along the longitudinal axis 210.
[0033] Each of the first electrode 114 and the second electrode 112 extends from a first end fixedly attached to the housing 200 at or near the distal end 202 to a second end. Figure 2In some examples, the second end is not attached to the housing 200 except via the first end. The first electrode 114 includes one or more coatings configured to define a first electroactive region 216, and the second electrode 112 includes one or more coatings configured to define a second electroactive region 214. In some examples, the second electroactive region 214 can be proximate to a second (e.g., distal) end of the second electrode 112, and the first electroactive region 216 can be proximate to either end of the first electrode 114. Figure 2 In the example of FIG. 1 , the first electroactive region 216 includes a distal end of the first electrode 114 .
[0034] The first electrode 114 and the second electrode 112 may be formed of a conductive material such as titanium, platinum, iridium, tantalum, or alloys thereof. The first electrode 114 and the second electrode 112 may be coated with an electrically insulating coating, such as parylene, polyurethane, silicone, epoxy, or other insulating coating, to reduce the conductive active surface area of the first electrode 112 and the second electrode 114, and thereby define the first and second electrically active regions 216, 214. Defining the first and second electrically active regions 216, 214 by covering portions with an insulating coating may increase the electrical impedance of the first and second electrodes 114, 112, and thereby reduce the current delivered during the capture of pacing pulses for cardiac tissue. The lower current consumption conserves the power source of the device 104, such as one or more rechargeable or non-rechargeable batteries.
[0035] In some examples, first electrode 114 and second electrode 112 may have a conductive material coating on first electroactive region 216 and second electroactive region 214 to define active regions. For example, first electroactive region 216 and second electroactive region 214 may be made of substantially similar materials, or may be made of different materials from each other.
[0036] exist Figure 2 In some examples, the second electrode 112 is in the form of a spiral. In some examples, the spiral is an object having a three-dimensional shape similar to a wire uniformly wound in a single layer around a cylindrical or conical surface, such that if the surface were unfolded into a plane, the wire would be a straight line.
[0037] like Figure 2 As shown, the second electrode 112 can be a right-handed wound spiral and the first electrode 114 can be a left-handed wound partial spiral, although in other examples the handedness of the electrodes can be switched or the electrodes can have the same handedness as each other. Figure 2In the example of the embodiment of the present invention, the partial spiral and the spiral defined by the first electrode 114 and the second electrode 112, respectively, have the same pitch, although in other examples they may have different pitches. In some examples, one or both of the electrodes 112 and 114 may have a shape other than a spiral. For example, the first electrode 114 may have a ring shape. As another example, the second electrode 112 configured to penetrate tissue of another chamber may be configured as one or more elongated darts, barbs, or tines.
[0038] The size and shape of the first electrode 114 and the second electrode 112 can also be varied to enhance tissue contact of the first electroactive region 216 and the second electroactive region 214. For example, the first electrode 114 and the second electrode 112 can have a circular cross-section, or can be made with a flatter cross-section (e.g., an elliptical or rectangular shape) based on tissue contact specifications. The size and shape of the first electrode 114 and the second electrode 112 can also be determined by stiffness requirements. For example, stiffness requirements can vary based on the expected implantation requirements, including the tissue in which the first electrode 114 and the second electrode 112 are implanted or contacted, and how long the device 104 is intended to be implemented.
[0039] The distal end of the second electrode 112 may have a conical, hemispherical, or beveled-edge distal tip with a narrow tip diameter, such as less than 1 millimeter (mm), for penetration into and through tissue layers. In some examples, the distal end of the first electrode may be a sharp or angled tip or a sharp or beveled edge, but the sharpness may be constrained to avoid a cutting action that may cause lateral displacement of the distal end of the second electrode 112 and undesirable tissue trauma. In some examples, the second electrode 112 may have a maximum diameter at its base where it meets the housing distal end 32. In such examples, the diameter of the second electrode 112 may decrease from the housing distal end 202 to the distal end of the second electrode 112.
[0040] The outer dimensions of the second electrode 112 can be substantially straight and cylindrical, wherein in some examples the second electrode 112 is rigid. In some examples, the first electrode 114 and the second electrode 112 can be flexible in the lateral direction, being non-rigid to allow some flexing with cardiac motion. In a relaxed state, when not subjected to any external forces, the first electrode 114 and the second electrode 112 can be configured to maintain a distance between the first electroactive region 216 and the second electroactive region 214 and the housing distal end 202.
[0041] The distal end of the second electrode 112 can penetrate one or more tissue layers to position the second electroactive region 214 within a desired tissue layer (e.g., ventricular myocardium or interventricular septum). Thus, the second electrode 112 extends from the housing distal end 202 a distance corresponding to the depth of the intended pacing site and can have a relatively high compressive strength along its longitudinal axis, which can be substantially similar to the longitudinal axis 210 to resist bending in a lateral or radial direction when longitudinal forces, axial forces, and / or rotational forces are applied to, for example, the proximal end 204 of the housing 200 to advance the device 104 into tissue at the target implantation area 102. When the second electrode 112 is a helical electrode, the second electrode 112 can maintain spacing between multiple windings of the second electrode 112 by resisting bending in a lateral or radial direction. The second electrode 112 can be longitudinally non-compressible. However, when subjected to lateral or radial forces, the first electrode 114 may also be elastically deformable in the lateral or radial direction to allow, for example, temporary flexing as tissue moves, but when the lateral force is reduced, the first electrode returns to its normal straight position. In some examples, when the second electrode 112 is not exposed to any external force or is only exposed to a force along its longitudinal axis (substantially similar to the longitudinal axis 210), the second electrode 112 maintains a straight linear position as shown.
[0042] In some examples, the first electrode 114 or the electrode 208 may be paired with the second electrode 112 for sensing ventricular signals and delivering ventricular pacing pulses. In some examples, the first electrode 114 may be paired with the electrode 208 or the second electrode 112 for sensing atrial signals and delivering pacing pulses to the atrial myocardium in the target implant area 102. In other words, in some examples, the electrode 208 may be paired with the second electrode 112 or the first electrode 114 at different times for ventricular functionality or atrial functionality, respectively. In some examples, the first electrode 114 and the second electrode 112 may be paired with each other at different polarities for atrial functionality and ventricular functionality.
[0043] In some examples, first electrode 114 may be configured as an atrial cathode electrode for delivering pacing pulses to atrial tissue at target implant region 102 in combination with electrode 208. First electrode 114 and electrode 208 may also be used to sense atrial P waves for controlling atrial pacing pulses (delivered in the absence of a sensed P wave), and for controlling atrial synchronized ventricular pacing pulses delivered using second electrode 112 as a cathode and electrode 208 as a return anode.
[0044] At the distal end 108, the device 104 includes a distal fixation assembly 212, which includes a first electrode 114, a second electrode 112, and a housing distal end 202. The distal end of the second electrode 112 can be configured to rest within the patient's ventricular myocardium, and the first electrode 114 can be configured to contact the patient's atrial endocardium. In some examples, the distal fixation assembly 212 can include more or fewer electrodes than two electrodes. In some examples, the distal fixation assembly 212 can include one or more second electrodes along the housing distal end 202. For example, the distal fixation assembly 212 can include three electrodes, which can be substantially similar or different from each other. The spacing between the multiple first electrodes 114 can be equal or unequal distances. The first electrode 114 can be individually selectively coupled to the sensing circuit and / or pacing circuit enclosed by the housing 200 to serve as an anode with the second electrode 112 or as an atrial cathode electrode, or can be electrically shared and not individually selectable.
[0045] The first electrode 114 can be configured to flexibly maintain contact with wall tissue (e.g., the RA endocardium) of the cardiac chamber in which the device 104 is implanted, regardless of changes in the tissue surface or in the distance between the distal end 202 of the housing 200 and the tissue surface, which may occur as the wall tissue moves during the cardiac cycle.
[0046] Although described in the context of a device 104 configured for implantation within a heart 100, the techniques of the present disclosure may be implemented in any device or system having first and second electrodes configured as described herein. For example, a device implanted outside of the heart (e.g., transthoracic or otherwise subcutaneously) may be coupled to one or more leads extending into the heart. The distal end of a single lead may include first and second electrodes configured as described herein (e.g., as described herein). Figure 2 114), the device can deliver pacing and sense electrical activity of the heart through the first and second electrodes as described herein. For example, a single lead can be located in a first chamber of the heart (e.g., an atrium such as the RA) with one of its electrodes in contact with tissue of the first chamber and another of its electrodes penetrating into tissue of a second, separate chamber of the heart (e.g., a ventricle such as the LV).
[0047] Figure 3 1 is a functional block diagram showing an exemplary configuration of the device 104. Figure 3 As shown, the device 104 includes electrodes 112 and 114, which can be as shown relative to Figure 1 and Figure 2 For example, as with respect to Figure 1 and Figure 2As described, the second electrode 112 may be configured to extend from the distal end 202 of the housing 200 and may penetrate the wall tissue of the first chamber (e.g., RA) into the wall tissue of the second chamber (e.g., LV). The first electrode 114 extends from the distal end 202 of the housing 200 and may be configured to flexibly maintain contact with the wall tissue of the first chamber without the first electrode penetrating the wall tissue of the first chamber.
[0048] exist Figure 3 In the example shown, the device 104 includes a switching circuit 302, a sensing circuit 304, a signal generating circuit 306, a sensor 308, a processing circuit 310, a telemetry circuit 312, a memory 314, and a power supply 316. The various circuits may be or include programmable or fixed function circuits that are configured to perform the functions attributed to the respective circuits. The memory 314 may store computer readable instructions that, when executed by the processing circuit 310, cause the device 104 to perform various functions. The memory 314 may be a storage device or other non-transitory medium. Figure 3 The components of the device 104 shown in FIG. 1 may be housed within a housing 200 .
[0049] The signal generating circuit 306 is configured to generate an excitation signal, for example, a cardiac pacing pulse. The signal generating circuit 306 may include, for example, a current source or a voltage source, a capacitor, a charge pump, or other signal generating circuit. The switching circuit 302 is coupled to the electrodes 112, 114, and 208, and may include one or more switch arrays, one or more multiplexers, one or more switches (e.g., a switch matrix or other switch set), one or more transistors or other circuits. The switching circuit 302 is configured to direct the excitation signal from the signal generating circuit 306 to a selected combination of electrodes 112, 114, and 208 having a selected polarity, for example, to selectively deliver a pacing pulse to the RA, ventricle, or interventricular septum of the heart 100. For example, in order to pace one or both of the ventricles, the switching circuit 302 may couple the second electrode 112 that penetrates the wall tissue of the ventricle or interventricular septum to the signal generating circuit 306 as a cathode, and couple one or both of the first electrode 114 or the electrode 208 to the signal generating circuit 306 as an anode. As another example, to pace the RA, the switch circuit 302 may couple the first electrode 114 that flexibly maintains contact with the RA endocardium to the signal generating circuit 306 as a cathode and couple the second electrode 112 or one or both of the electrodes 208 to the signal generating circuit 306 as an anode.
[0050] The switch circuit 302 may also selectively couple the sensing circuit 304 to a selected combination of the electrodes 112, 114, and 208, for example, to selectively sense electrical activity of the atria or ventricles of the heart 100. The sensing circuit 304 may include a filter, an amplifier, an analog-to-digital converter, or other circuitry configured to sense cardiac electrical signals via the electrodes 112, 114, and 208. For example, the switch circuit 302 may couple each of the second electrode 112 and the first electrode 114 (in combination with the electrode 208) to a respective sensing channel provided by the sensing circuit 304 to sense ventricular cardiac electrical signals or atrial cardiac electrical signals, respectively. In some examples, the sensing circuit 304 is configured to detect events within the cardiac electrical signals, such as depolarizations, and provide indications thereof to the processing circuit 310. In this manner, the processing circuit 310 may determine the timing of atrial depolarizations and ventricular depolarizations, and control the delivery of cardiac pacing (e.g., AV synchronized cardiac pacing) based on the timing.
[0051] In some examples, sensing circuit 304 can be configured to sense and record electrical activity within a first chamber (e.g., RA) of heart 100 and a second chamber (e.g., LV) of heart 100. In some examples, electrical activity with the first chamber and / or the second chamber can represent capture of the corresponding chambers. For example, sensing circuit 304 can detect electrical activity in the RA corresponding to atrial capture, and can also detect electrical activity in the LV corresponding to ventricular capture.
[0052] The processing circuit 310 may include any one or more of the following: a microprocessor, a controller, a digital signal processor (DSP), an application-specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuits, or any other processing circuit configured to provide the functionality attributed to the processing circuit 310, which may be embodied herein as firmware, hardware, software, or any combination thereof.
[0053] Processing circuit 310 can be configured to identify the presence of capture of tissue of a second chamber (e.g., LV) in response to delivery of cardiac pacing to a first chamber (e.g., RA). Capture of tissue of a second chamber can also be referred to as cross-chamber capture. In some examples, processing circuit 310 can use sensed data from sensing circuit 304 to identify the presence of capture.
[0054] In some examples, processing circuit 310 can be configured to send instructions to signal generation circuit 306 and / or switch circuit 302 in response to the captured identification to modify one or more excitation signals, e.g., pacing pulses. Modification of one or more excitation signals can include adjusting the pulse amplitude, pulse width, and / or frequency of each excitation signal. In some examples, modification of one or more excitation signals can include termination of delivery of the excitation signal to the second chamber.
[0055] Sensor 308 may include one or more sensing elements that convert patient physiological activity into electrical signals to sense the value of a corresponding patient parameter. Sensor 308 may include one or more accelerometers, optical sensors, chemical sensors, temperature sensors, pressure sensors, or any other type of sensor. Sensor 308 may output a patient parameter value that may be used as feedback to control the sensing and delivery of therapy by device 104.
[0056] Telemetry circuitry 312 (also referred to as “communication circuitry 312”) supports wireless communication between device 104 and an external programmer or another computing device, such as computing device 120, under the control of processing circuitry 310. Processing circuitry 310 of device 104 may receive updates to operating parameters from computing device 120 and provide collected data, such as sensed cardiac activity or other patient parameters, to computing device 120 via telemetry circuitry 312. In some examples, processing circuitry 310 of device 104 may send a notification to computing device 120 via telemetry circuitry 312 that processing circuitry 310 has identified capture of wall tissue of a second chamber (e.g., LV) of heart 100 as a result of an excitation signal delivered by device 104 to a first chamber (e.g., RA) of heart 100. Telemetry circuitry 312 may enable communication via radio frequency (RF) communication techniques, such as via an antenna (not shown).
[0057] Figure 4 is implanted at the target implantation area 102 Figure 1 or Figure 2 104. The second electrode 112 can be inserted so that the tissue engages with the helix of the second electrode 112. When the second electrode 112 engages with the tissue, the second electrode 112 penetrates into the tissue at the target implantation area 102 and advances through the atrial myocardium 404 and the central fiber body 406 to position the second electrically active region 214 in the ventricular myocardium 106, as shown in FIG. Figure 4 In some examples, the second electrode 112 penetrates into the interventricular septum. In some examples, the second electrode 112 does not completely penetrate the ventricular endocardial surface or the epicardial surface.
[0058] In some examples, manual pressure applied to the proximal end 204 of the housing, for example via an advancement tool, provides a longitudinal force to pierce cardiac tissue at the target implantation region 102. In some examples, actuation of the advancement tool causes the device 104 and the second electrode 112 configured as a helix to rotate about the longitudinal axis 210. The rotation of the helix about the longitudinal axis 210 causes the second electrode 112 to be advanced through the atrial myocardium 404 and the central fiber body 406 to position the second electrically active region 214 in the ventricular myocardium 106, as shown. Figure 4 shown.
[0059] As the second electrode 112 is advanced into the tissue, the distance between the first electrode 114 and the atrial endocardium 402 decreases until the first electrode 114 contacts the surface of the atrial endocardium 402 and may be pressed against the surface of the atrial endocardium such that the cardiac tissue engages the first electrically active area 216. The first electrode 114 is maintained in contact with the atrial endocardium 402 by the second electrode 112, e.g., the first electrode 114 is prevented from retracting from the surface of the atrial endocardium 402 by the second electrode 112.
[0060] In some pacing applications, the target implant area 102 is along the atrial endocardium 402, substantially below the AV node and the bundle of His. The second electrode 112 may have a length that penetrates the atrial endocardium 402 in the target implant area 102, passes through the central fiber body 406, and enters the ventricular myocardium 106 without penetrating the ventricular endocardial surface. In some examples, when the full length of the second electrode 112 is fully advanced into the target implant area 102, the second electrically active area 214 rests within the ventricular myocardium 106, and the first electrode 114 is positioned in close contact with the atrial endocardium 402. In various examples, the second electrode 112 may extend from the housing distal end 202 by about 3 millimeters (mm) to 12 mm. In some examples, the second electrode 112 may extend from the housing 200 a distance of at least 3 mm, in various examples at least 3 mm but less than 20 mm, less than 15 mm, less than 10 mm, or less than 8 mm. The diameter of the first electrode 114 and the second electrode 112 may be less than 2 mm, and may be less than or equal to 1 mm, or even less than or equal to 0.6 mm.
[0061] Figure 5 is a block diagram illustrating an exemplary configuration of computing device 120. Computing device 120 may include a user interface (UI) 318, processing circuitry 320, telemetry circuitry 322, memory 324, and power supply 326. User interface 318 may transmit information and / or retrieve data and instructions from a user, such as a patient or clinician. In some examples, user interface 318 may transmit to the user an indication that a cross-chamber capture (e.g., capture of a second chamber of heart 100) has been identified by device 104. In other examples, user interface 318 may receive instructions from the user for processing the identified cross-chamber capture and transmit the instructions to processing circuitry 320.
[0062] Processing circuitry 320 may identify the presence of cross-chamber capture based on data transmitted from device 104 (e.g., from telemetry circuitry 312 of device 104 to telemetry circuitry 322 of computing device 120). Processing circuitry 320 may also determine program parameters (e.g., cardiac pacing parameters, sensing parameters) that control the operation of device 104. In some examples, processing circuitry 322 may determine a response to the identification of the presence of cross-chamber capture and instruct telemetry circuitry 322 to transmit instructions to device 104 to implement the response. For example, processing circuitry 320 may determine that the response to the identification of cross-chamber capture is to switch device 104 from dual-chamber mode to single-chamber mode. Processing circuitry 320 may then instruct telemetry circuitry 322 to transmit instructions to device 104 to switch to single-chamber mode, such as via telemetry circuitry 312 of device 104.
[0063] Memory 324 may store data received by computing device 120 from a user and / or device 104. In some examples, memory 324 may store instructions for processing circuit 322 to execute to identify and / or respond to presence captured across chambers. Power supply 326 provides power to other components of computing device 120. Power supply 326 may be rechargeable and / or removable.
[0064] Figure 6 and Figure 7 is a graph of exemplary electrocardiogram (EGM) graphs showing the activity of the first chamber of the heart 100 and the second chamber of the heart 100 under different conditions. Figure 6 and Figure 7 The figures relate to the RA as the first chamber of the heart 100 and the LV as the second chamber of the heart 100 , but the present disclosure may relate to other combinations of chambers of the heart 100 .
[0065] Figure 6 is a graph of an exemplary EGM graph 500 illustrating atrial pacing without inducing ventricular capture. The EGM graph 500 illustrates a first chamber electrical signal 508, a corresponding second chamber electrical signal 512, and a marker channel 502 over a set time period. The marker channel 502 is configured to annotate events in the first chamber electrical signal 508 and the second chamber electrical signal 512. The annotations may include an atrial event marker 504 and a ventricular event marker 506. The atrial event marker 504 includes a label (e.g., AP indicating atrial pacing) indicating that a pacing pulse was delivered to the RA, resulting in a pacing polarization artifact and an induced P wave 510 visible on the first chamber electrical signal 508. The ventricular event marker 506 indicates a ventricular event, for example, in the LV, and includes a label (e.g., VS indicating ventricular sense). The marker channel 502 displays a time interval T1 between the atrial event marker 504 and the ventricular event marker 506. In some examples, as Figure 6As shown, first chamber electrical signal 508 can be related to an electrical signal within RA sensed by device 104, for example, via sensing circuit 304, first electrode 114 (e.g., in first electroactive region 216), and electrode 208. In some examples, as shown in FIG. Figure 6 As shown, second chamber electrical signal 512 may be related to an electrical signal within the LV sensed by device 104 , for example, via sensing circuit 304 , second electrode 112 (eg, in second electro-active region 214 ), and electrode 208 .
[0066] The first chamber electrical signal 508 may illustrate an electrical signal of the first chamber (eg, RA) in response to delivery of the stimulation signal through the device 104. Figure 6 As shown, the first chamber electrical signal 508 may represent one or more P waves 510. The P wave represents the depolarization of the RA in response to the excitation signal from the device 104. The second chamber electrical signal 512 shows the electrical signal corresponding to the response of the second chamber (e.g., LV) to the depolarization of the RA. Figure 6 As shown, the second chamber electrical signal 512 may represent the Q wave, R wave, and S wave (collectively referred to as "QRS complex wave 514") of the LV and RV. The QRS complex wave 514 represents the depolarization of the LV. Figure 6 As shown, time interval T1 is approximately 150 milliseconds (ms). In other examples, time interval T1 may be between 110 ms and 250 ms, depending on the patient's physiology, the health of heart 100, and the excitation signal parameters. The excitation signal parameters may include the frequency of signal delivery and the pulse width and pulse amplitude of the excitation signal. In some examples where time interval T1 is below a certain threshold (e.g., approximately 40 ms) or if there is an abrupt change in the patient's average time interval, computing device 120 may determine that the length of time interval T1 may be attributed solely to non-physiological causes and that there is capture of ventricular tissue as a result of the atrial excitation signal. Figure 6 In the example shown, the length of the time interval is approximately 150 ms. Thus, computing device 120 may determine that there is no capture of ventricular tissue.
[0067] Figure 7 600 is a graph showing an exemplary EGM graph captured of the LV in response to delivery of an excitation signal to the RA. The first chamber electrical signal 508 shows a P wave 510 corresponding to depolarization of the RA in response to delivery of the excitation signal by the device 104, e.g., via the first electrode 114, into the wall tissue of the RA. The second chamber electrical signal 512 shows the response of the QRS complex 602 to the excitation signal. Figure 7 In the example shown, the time interval T2 is 40 ms, which is below the threshold, and the computing device 120 will determine the presence of capture of the LV.
[0068] Figure 8 is a flow chart illustrating an exemplary method 700 for detecting capture of a second chamber in response to delivery of an excitation signal to a first chamber. The exemplary method 700 may be performed using an implantable medical device (e.g., Figures 1 to 4 104). Although exemplary method 700 involves RA as the first chamber of heart 100 and LV as the second chamber of heart 100, other exemplary methods may involve different chambers of heart 100. In other examples, the first chamber and the second chamber of heart 100 may be other combinations of atria and / or ventricles. For example, the first chamber may be LA and the second chamber may be RV, in which case exemplary method 700 may involve detecting capture of the second chamber (RV) in response to delivery of an excitation signal to the first chamber (LA), also referred to as cross-chamber capture. In some examples, the methods discussed in the present disclosure may include more or fewer steps than exemplary method 700. In other examples, exemplary method 700 may be performed using an implantable medical device having a design different from that of FIG. 104. For example, the implantable medical device may be implanted outside of heart 100, with one or more leads extending from outside of heart 100 into RA. In other examples, the implantable medical device may be configured to deliver the excitation signal to both the first chamber and the second chamber, but also be configured to detect the presence of cross-chamber capture in the third chamber and / or the fourth chamber. For example, the device may be configured to deliver the excitation signal to the LA and / or RA, and be configured to detect the presence of capture in the RV and / or LV, respectively. Furthermore, although described as being performed by the device 104 (e.g., the processing circuit 310 of the device 104), Figure 8 The example techniques of may be performed at least in part by processing circuitry of another device, such as processing circuitry 320 of computing device 120 that is in wireless communication with device 104 via telemetry circuitry 322 .
[0069] The device 104 delivers atrial pacing therapy to atrial tissue (702). The atrial pacing therapy may include one or more excitation signals configured to induce depolarization of a first chamber (e.g., RA) at a predetermined pace. Parameters of the atrial pacing therapy may be determined by an external programmer and / or an external computing device (e.g., via telemetry circuit 312) connected to the device 104. In some examples, the parameters of the atrial pacing therapy may be stored in a memory 314 of the device 104. In some examples, the parameters of the atrial pacing therapy may be stored in a memory 324 of the computing device 120. In some examples, the processing circuit 310 of the device 104 may be configured to determine an appropriate atrial pacing therapy for the RA of the heart 100. The device 104 may deliver the atrial pacing therapy to the atrial tissue via a first electrode 114 in contact with the wall tissue of the RA.
[0070] The device 104 then detects a signal in the ventricular tissue of the RV, such as an activation or depolarization signal (704), and determines a time interval between the delivery of atrial pacing therapy and the detection of the signal in the ventricular tissue (706). The device 104 may detect the signal in the ventricular tissue of the LV via the sensing circuit 304 and the second electrode 112 (704). The signal may be similar to Figure 7 508, and may represent a QRS complex of the LV. The time interval between the delivery of the atrial pacing therapy and the detection of the signal in the ventricular tissue may represent a PR interval, which may represent a time interval between the start of the P wave in the RA and the start of the QRS complex in the LV. In some examples, the processing circuit 310 of the device 104 may be configured to determine the time interval between the delivery of the atrial pacing therapy and the detection of the signal in the ventricular tissue.
[0071] Device 104 also determines whether the time interval is shorter than (or less than or equal to) a threshold time interval (708). In some examples, processing circuitry 310 of device 104 may determine whether the time interval is shorter than a threshold time interval. The threshold time interval may be a measurement of the time between atrial pacing therapy and a signal in ventricular tissue that may indicate the presence of ventricular capture. In some examples, the threshold time interval may be 110 ms or less or 80 ms or less. The threshold time interval may represent a short time interval where there is a high probability that the length of the time interval is a result of ventricular capture rather than the patient's physiology (e.g., the health of heart 100, a change in the health of heart 100). In some examples, the threshold time interval may be based on previously recorded time intervals for the patient. For example, the threshold time interval may be half of the median time interval for the previous week or month. Processing circuitry 310 may determine the threshold time interval using sensing data stored in memory 314 of device 104, an external programmer, a computing device (e.g., computing device 120), a remote server, and / or the cloud.
[0072] Processing circuit 310 may be configured to periodically and automatically determine whether the time is shorter than a threshold time interval (708). Processing circuit 310 may make the determination on an hourly and / or daily basis. In some examples, processing circuit 310 may make the determination as part of one or more other routine tests performed on device 104. In some examples, processing circuit 310 may be configured to make the determination based on instructions from an external programmer and / or computing device.
[0073] If the time interval is not shorter than the threshold time interval (the "NO" branch of 708), the device 104 resumes delivering atrial pacing therapy to the atrial tissue (702). If the time interval is shorter than the threshold time interval (the "YES" branch of 708), the device 104 has identified the presence of capture of the second chamber (e.g., ventricular tissue of the LV, referred to herein as "ventricular capture") as a result of the atrial pacing therapy, and the atrial pacing therapy may be adjusted, for example, by the processing circuit 310 of the device 104. In some examples, the device 104 may need to determine that a threshold number of time intervals shorter than the threshold time interval has been met before determining that the device 104 has identified the presence of capture of the second chamber (i.e., cross-chamber capture). The threshold number of time intervals may be the number of short time intervals within a set number of detected intervals. For example, the device 104 may identify the presence of capture of the second chamber when it is determined that six of the first ten detected time intervals are shorter than the threshold time interval. In other examples, the threshold number may be the number of consecutive time intervals that are shorter than the threshold time interval.
[0074] In some examples, device 104 may adjust atrial pacing therapy based on instructions from an external programmer or computing device (e.g., computing device 120). In some examples, processing circuit 310 may adjust atrial pacing therapy by disabling delivery of excitation signals to the RAs. Processing circuit 310 may temporarily or permanently disable delivery of excitation signals to the RAs. If processing circuit 310 temporarily disables delivery of excitation signals, processing circuit 310 may re-enable delivery of excitation signals after expiration of a time period. In other examples, processing circuit 310 may re-enable delivery of excitation signals upon determining that ventricular capture no longer exists. In some examples, processing circuit 310 may permanently disable delivery of excitation signals until processing circuit 310 receives instructions from computing device 120 and through telemetry circuit 312 to re-enable delivery of excitation signals to the RAs.
[0075] In some examples, the processing circuit 310 may adjust the atrial pacing therapy by adjusting one or more parameters of the atrial pacing therapy. The processing circuit 310 may adjust the parameters of the atrial pacing therapy by reducing the frequency, pulse width, and / or pulse amplitude of the excitation signal. In some examples, the processing circuit 310 may configure a maximum adaptive atrial amplitude or a maximum adaptive pulse width within the atrial capture management feature of the device 104. For example, the processing circuit 310 may set a maximum value to which the device 104 may adjust these values in response to a loss of atrial capture. In some examples, the processing circuit 310 may switch the device 104 from a dual chamber mode (e.g., a dual chamber pacing mode) to a single chamber mode (e.g., a single chamber synchronous pacing mode (VDD)). The processing circuit 310 may switch the device 104 from the single chamber mode to the dual chamber mode after expiration of a particular time period or in response to a determination that ventricular capture is no longer present. In some examples, processing circuitry 310 may switch device 104 from the single chamber mode to the dual chamber mode in response to an instruction from computing device 120 .
[0076] In some examples, processing circuit 310 may confirm in the confirming step that ventricular capture is occurring before adjusting atrial pacing therapy. When ventricular capture is further confirmed in the confirming step, processing circuit 310 may then adjust atrial pacing therapy. If processing circuit 310 does not confirm ventricular capture, device 104 may return to detecting a signal in ventricular tissue (704). Although exemplary method 800 involves RA as a first chamber of heart 100 and LV as a second chamber of heart 100, other exemplary methods may involve different chambers of heart 100.
[0077] In some examples, processing circuit 310 may also send a notification to an external programmer and / or computing device 120, such as via telemetry circuit 312 of device 104, that processing circuit 310 has identified the presence of ventricular capture. In some examples, processing circuit 310 may send a notification to one or more mobile computing devices, such as a laptop or mobile phone.
[0078] Fig. 9 is a flow chart illustrating an exemplary method for confirming detection of capture of a second chamber in response to delivery of an excitation signal to a first chamber. Although described as being performed by device 104 (eg, processing circuitry 310 of device 104), Fig. 9 The exemplary method may be performed at least in part by processing circuitry of another device, such as processing circuitry 320 of computing device 120.
[0079] Device 104, for example, according to the present invention Figure 8The disclosed example determines a time interval between the delivery of atrial pacing therapy and the detection of the signal (706). The device 104 then determines whether the device 104 has detected a threshold number of time intervals (eg, N of the M intervals) that are shorter than a first threshold time interval (712).
[0080] If the device 104 does not detect a threshold number of time intervals that are shorter than the first threshold time interval, e.g., if fewer than N of the M time intervals are shorter than the first threshold time interval (the "No" branch of 712), the device 104 resumes determining the time interval between the delivery of the atrial pacing therapy and the detection of the signal (706). In some examples, as a result of determining that the device 104 did not detect the threshold number of time intervals (the "No" branch of 712), the device 104 may also stop detecting the depolarization signal in the ventricular tissue for a set period of time (e.g., until a timer expires). If the device 104 detects a threshold number of time intervals that are shorter than the first threshold time interval, e.g., if the device 104 detects at least N of the M time intervals are shorter than the first threshold time interval (the "Yes" branch of 712), the device 104 enters a ventricular capture confirmation mode (714).
[0081] When the device 104 is in the ventricular capture confirmation mode, the device 104 may continue to detect depolarization signals in the ventricular tissue and determine corresponding time intervals. The device 104 may adjust the AA pacing rate of the pacing therapy and set the timer (716). The AA pacing rate may include the frequency at which the device 104 outputs the stimulation signal, for example, the number of stimulation signals (e.g., atrial pacing signals) output by the device 104 in a given time period. The device 104 may adjust the AA pacing rate by increasing the frequency of stimulation signal output or shortening the time interval between consecutive stimulation signals.
[0082] The device 104 may determine a second time interval between the delivery of atrial pacing therapy and the detection of a ventricular depolarization signal (718), for example, according to the examples discussed herein. If the device 104 does not detect a second threshold number of time intervals shorter than the second threshold time interval while in the ventricular capture confirmation mode, for example, if less than P of the Q time intervals are shorter than the second threshold time interval (the "No" branch of 720), the device 104 exits the ventricular capture confirmation mode (722). When the device 104 is not in the ventricular capture confirmation mode, the device 104 may determine whether the timer has expired (726). If the device 104 determines that the timer has expired (the "Yes" branch of 726), the device 104 may determine the time interval between the delivery of atrial pacing therapy and the detection of a ventricular depolarization signal (706) and restart the process. If the device 104 determines that the timer has not expired (the "No" branch of 726), the device 104 must wait (for example, for a period of time such as 722). Fig. 9 The device 104 may determine that the timer has expired (step 722 shown) until the device 104 determines that the timer has expired (726). In some examples, the timer may be determined based on user input through the UI 318 of the computing device 120, or may be determined by the device 104 and / or computing device 120 based on previous data.
[0083] If device 104 detects a second threshold number of time intervals, e.g., if device 104 detects at least P time intervals of the Q time intervals that are shorter than the second threshold time interval ("YES" branch of 720), device 104 adjusts the atrial pacing configuration (724). In some examples, the second threshold number of time intervals may be satisfied by a single time interval that is shorter than the second threshold time interval.
[0084] Fig.10 8 is a flow chart illustrating an exemplary method 800 for detecting capture of a second cavity in response to delivery of an excitation signal to a first cavity during implantation of an implantable medical device (e.g., device 104). Although described as being performed by device 104 (e.g., processing circuitry 310 of device 104), Fig.10 The exemplary techniques of may be performed at least in part by processing circuitry of another device, such as processing circuitry 320 of computing device 120. In some examples, the executable Fig.10 Exemplary techniques are provided for use with one or more implantable medical leads for implanting a medical device.
[0085] To begin the exemplary method 800, a user (e.g., a physician, a clinician) first implants the device 104 into the patient's heart 100 (802) and initiates an implant diagnostic process (804). As part of the implant diagnostic process, the processing circuit 310 may instruct the signal generation circuit 306 and the switch circuit 304 of the device 104 to deliver a test excitation pulse to the atrial wall tissue of the RA. The device 104 also detects signals from a first heart chamber and a second heart chamber (e.g., RA and LV, respectively) in response to the test excitation pulse (805). The device 104 may determine whether the excitation pulse captured the first chamber or the second chamber based on the signal. The device 104 may detect the signal using the sensing circuit 304, the sensor 308, and the electrodes 112, 114, and 208. The electrical signal may be similar to, for example, Figure 7 The first chamber electrical signal 602 and the second chamber electrical signal 604 are shown. The test excitation pulses can be pulses having different frequencies, pulse widths, and pulse amplitudes. The device 104 can deliver the test excitation pulses into the atrial wall tissue of the RA to determine a suitable combination of parameter settings for the patient. The device 104 can also determine an atrial capture threshold (806) for the heart 100. The atrial capture threshold can be a combination of pacing settings that capture the atrium and can include a range of frequencies, pulse widths, and pulse amplitudes of the excitation signals delivered by the device 104. In some examples, the processing circuit 310 can determine the atrial capture threshold based on detecting capture of the atrium via the electrodes 114 and the sensing circuit 304.
[0086] The device 104 may determine a cross-chamber capture threshold (807) and may determine a maximum atrial pacing output before ventricular capture occurs (808). The cross-chamber capture threshold may be a minimum parameter of an atrial excitation signal that may trigger ventricular capture and may be defined by a frequency, a pulse width, and a pulse amplitude of the atrial excitation signal. The maximum atrial pacing output may be a maximum parameter of an atrial excitation signal that does not meet the cross-chamber capture threshold. In some examples, an atrial excitation signal having a higher frequency, a larger pulse width, and / or a higher pulse amplitude than the maximum atrial pacing output will trigger ventricular capture in the heart 100. In some examples, the processing circuit 310 of the device 104 may determine the cross-chamber capture threshold and the maximum atrial pacing output.
[0087] The device 104 or another device (such as the computing device 120) or a user may also determine whether the atrial capture threshold is substantially similar to the maximum pacing output (810). If the atrial capture threshold is substantially similar to the maximum atrial pacing output, the delivery of atrial pacing has a significant likelihood of triggering ventricular capture and / or may not be safely maintained without triggering cross-chamber capture. In some examples, the processing circuit 310 determines whether the atrial capture threshold is substantially similar to the maximum pacing output (810). Substantially similar may mean that there is less than a threshold difference between the atrial capture threshold and the maximum atrial pacing output. In some examples, the threshold difference may be a safety margin value, and if the net voltage of the sum of the atrial capture threshold and the safety margin value is equal to or exceeds the cross-chamber capture threshold, the atrial capture threshold may be substantially similar to the maximum pacing output. In some examples, the safety margin value may be between about 0.5V and about 1.5V. In some examples, the threshold difference can be a safety margin factor, and if the net voltage of the atrial capture threshold multiplied by the safety margin factor equals or exceeds the cross-chamber capture threshold, the atrial capture threshold can be substantially similar to the maximum pacing output. In some examples, the safety margin factor can be between about 1.5 and about 2.5.
[0088] If the device 104, computing device 120, or user determines that the atrial capture threshold is not substantially similar to the maximum pacing output (the "NO" branch of 810), the user may complete the implantation process (814). In some examples, the processing circuit 310 may send a notification to the external programmer and / or computing device that there is no risk of cross-chamber capture by the device 104. In some examples, as part of the atrial pacing threshold test, the processing circuit 310 may be configured to automatically increase the atrial pacing output as the atrial capture threshold of the device 104 increases. As part of completing the implantation process (814), the processing circuit 310 may be further configured to determine a maximum adaptive amplitude for atrial pacing such that the potential output of the device 104 does not exceed the maximum atrial pacing output, such as a threshold at which atrial pacing results in ventricular capture (or a determination based on the threshold).
[0089] If the device 104, computing device 120, or a user determines, for example, via processing circuitry 310 of device 104, that the atrial capture threshold is substantially similar to the maximum pacing output ("yes" branch of 810), the user may reposition the device 104 within the RA (812). In some examples, the user repositions the device 104 within the RA such that the first electrode 114 and the second electrode 112 are fixed at locations within the target zone 102. In some examples, processing circuitry 310 may send a notification to an external programmer and / or computing device, for example, via a network, that the device 104 needs to be repositioned within the RA. In some examples, processing circuitry 310 may send a notification to an external programmer and / or computing device to reposition the device from a first location within the RA to a second location within the RA.
[0090] Once the user repositions the device 104 within the RA (812), the device 104 re-initiates the implant diagnostic process (804) according to the process discussed above. In some examples, the device 104 may notify the user that the device 104 needs to be repositioned after the device 104, the computing device 120, or the user determines that the atrial capture threshold is substantially similar to the maximum atrial pacing output. If the device 104 determines that a certain number of selected atrial pacing therapies are substantially similar to the maximum pacing output, the device 104 may notify the user that the device 104 needs to be repositioned.
[0091] It should be understood that the various aspects disclosed herein may be combined in combinations different from those specifically presented in the specification and drawings. It should be understood that, according to examples, certain actions or events of any of the processes or methods described herein may be performed in a different order, may be added, merged, or omitted entirely (e.g., not all described actions or events may be required to perform these techniques). In addition, although for clarity, certain aspects of the present disclosure are described as being performed by a single module or unit, it should be understood that the techniques of the present disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
[0092] In one or more examples, the described techniques can be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions can be stored as one or more instructions or codes on a computer-readable medium and executed by a hardware-based processing unit. The computer-readable medium may include a non-transitory computer-readable medium that corresponds to a tangible medium, such as a data storage medium (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and can be accessed by a computer).
[0093] In addition, it should be noted that the systems described herein may not be limited to the treatment of human patients. In alternative examples, the systems may be implemented in non-human patients, such as primates, canines, equines, pigs, and felines. These other animals may undergo clinical or research treatments that may benefit from the subject matter of the present disclosure.
[0094] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuits. Thus, the term "processor" as used herein may refer to any of the foregoing structures or any other physical structure suitable for implementing the described techniques. Additionally, these techniques may be fully implemented in one or more circuits or logic elements.
[0095] Embodiment 1: A device comprising: a housing; a first electrode and a second electrode, the first electrode and the second electrode extending from the housing, wherein the first electrode contacts tissue of a first chamber of the heart, and wherein the second electrode is configured to penetrate into tissue of a second chamber of the heart separate from the first chamber of the heart; a sensing circuit, the sensing circuit being within the housing, wherein the sensing circuit is configured to sense electrical activity of the first chamber via the first electrode and to sense electrical activity of the second chamber via the second electrode; a therapy delivery circuit, the therapy delivery circuit being within the housing, wherein the therapy delivery circuit is configured to deliver cardiac pacing to the first chamber via the first electrode and to deliver cardiac pacing to the second chamber via the second electrode; and a processing circuit, the processing circuit being within the housing, wherein the processing circuit is configured to: identify capture of the tissue of the second chamber in response to delivery of cardiac pacing to the first chamber by the therapy delivery circuit based on the sensed electrical activity of the second chamber; and adjust the cardiac pacing to the first chamber based on identification of the capture of the second chamber.
[0096] Embodiment 2: A device according to embodiment 1, wherein in order to identify the capture of the second chamber in response to the delivery of cardiac pacing to the first chamber by the therapy delivery circuit via the first electrode, the processing circuit is configured to: determine a time interval from when a signal is sensed by the sensing circuit via the second electrode; compare the time interval with a threshold time interval; and identify the capture based on the comparison.
[0097] Embodiment 3: The device of Embodiment 2, wherein the time interval comprises a time interval from the delivery of the cardiac pacing via the first electrode to the sensing of the signal via the second electrode.
[0098] Embodiment 4: The apparatus of Embodiment 2 or 3, wherein the processing circuit is configured to determine the threshold time interval using one or more previously recorded time intervals.
[0099] Embodiment 5: A device according to any one of Embodiments 2 to 4, wherein the processing circuit is configured to identify the capture of the tissue of the second chamber based on the delivery of cardiac pacing to the first chamber by identifying that the amount of pacing pulses delivered to the first chamber that capture the second chamber meets a threshold.
[0100] Example 6: The device of any one of Examples 2 to 5, wherein the processing circuit is configured to confirm the capture of the tissue of the second chamber before adjusting the delivery of cardiac pacing.
[0101] Example 7: An apparatus according to Example 6, wherein the time interval includes a first time interval, and in order to confirm the capture of the tissue of the second chamber, the processing circuit is configured to: compare one or more second time intervals from the delivery of cardiac pacing to the first chamber to the sensing of the signal in the second chamber with a second threshold time interval, wherein the second threshold time interval is shorter than the threshold time interval; and determine that a threshold number of the one or more second time intervals is shorter than the second threshold time interval.
[0102] Embodiment 8: The device of any one of embodiments 1 to 7, wherein the second chamber is a ventricle.
[0103] Embodiment 9: The device of any one of embodiments 1 to 8, wherein the first chamber is an atrium.
[0104] Example 10: The device of any one of Examples 1 to 9, wherein in order to adjust the cardiac pacing to the first chamber, the processing circuit is configured to adjust the delivery of the cardiac pacing.
[0105] Example 11: The apparatus of Example 10, wherein the processing circuit is configured to adjust the delivery of the cardiac pacing by disabling delivery of the cardiac pacing to the first chamber in response to the identification of the capture of the tissue of the second chamber.
[0106] Example 12: The device of Example 11, wherein the processing circuit is further configured to re-enable the delivery of the cardiac pacing to the first chamber in response to at least one expiration of a time period or a user command.
[0107] Example 13: A device according to any of Examples 10 to 12, wherein the processing circuit is further configured to adjust the delivery of the cardiac pacing by switching the device from a dual-chamber pacing mode to a single-chamber pacing mode in response to the identification of the capture of the tissue of the second chamber.
[0108] Embodiment 14: A device according to any one of embodiments 10 to 13, wherein the processing circuit is configured to adjust the delivery of the cardiac pacing by maintaining the device in a dual chamber sensing mode in response to the identification of the capture of the tissue of the second chamber.
[0109] Example 15: A device according to any one of Examples 1 to 9, wherein in order to adjust the cardiac pacing to the first chamber, the processing circuit is configured to adjust one or more settings affecting the cardiac pacing.
[0110] Example 16: The apparatus of Example 15, wherein the one or more settings affecting the cardiac pacing include a maximum amplitude of a pacing output for the cardiac pacing.
[0111] Example 17: The device of any one of Examples 1 to 9, wherein in order to adjust the cardiac pacemaker to the first chamber, the processing circuit is configured to adjust the pacing output of the cardiac pacemaker.
[0112] Example 18: The apparatus of Example 17, wherein in order to adjust the pacing output of the cardiac pacemaker, the processing circuit is configured to control the therapy delivery circuit to reduce the pulse magnitude of the cardiac pacemaker.
[0113] Example 19: The apparatus of any one of Examples 17 and 18, wherein in order to adjust the pacing output of the cardiac pacemaker, the processing circuit is configured to control the therapy delivery circuit to reduce the pulse width of the cardiac pacemaker.
[0114] Embodiment 20: The device of any one of Embodiments 1 to 19, wherein the processing circuit is configured to identify the capture of the tissue by the second chamber in response to a command from a user.
[0115] Embodiment 21: According to the device described in any one of embodiments 1 to 20, the device also includes a communication circuit, the communication circuit is within the housing, and the processing circuit is configured to send a notification to an external device via the communication circuit in response to the identification of the capture of the tissue in the second chamber.
[0116] Embodiment 22: The device of any one of Embodiments 1 to 21, wherein the device is capable of being implanted entirely within the first chamber of the heart.
[0117] Embodiment 23: The device of any one of Embodiments 1 to 22, wherein the first electrode and the second electrode are electrically coupled to a lead, and wherein the lead is configured to extend outside the heart to the housing.
[0118] Embodiment 24: The device of any one of Embodiments 1 to 23, wherein the device further comprises a return electrode, and wherein the sensing circuit is further configured to sense the electrical activity of the first chamber and the electrical activity of the second chamber via the return electrode.
[0119] Example 25: The device of Example 24, wherein the therapy delivery circuit is further configured to deliver cardiac pacing to the first chamber and the second chamber via the return electrode.
[0120] Example 26: A method comprising: delivering cardiac pacing from a device via a first electrode of the device to a first chamber of the heart; sensing electrical activity in a second chamber of the heart separated from the first chamber of the heart by the device and via a second electrode of the device penetrating into tissue of the second chamber; in response to the delivery of cardiac pacing to the first chamber, identifying capture of the tissue of the second chamber by the device and based on the sensed electrical activity of the second chamber; and in response to the identification of the capture of the second chamber, adjusting by the device the cardiac pacing to the first chamber performed by the therapy delivery circuit.
[0121] Example 27: A method according to Example 26, wherein the capture of the tissue of the second chamber in response to the delivery of cardiac pacing to the first chamber via the first electrode includes: determining a time interval to a signal sensed by the sensing circuit via the second electrode; comparing the time interval to a threshold time interval; and identifying the capture based on the comparison.
[0122] Embodiment 28: The method of Embodiment 27, wherein the time interval comprises a time interval from the delivery of the cardiac pacing via the first electrode to the signal sensed via the second electrode.
[0123] Embodiment 29: The method according to any one of embodiments 27 and 28, further comprising determining the threshold time interval using one or more previously recorded time intervals.
[0124] Example 30: A method according to any one of Examples 27 to 29, wherein identifying the capture of the tissue of the second chamber includes identifying an amount of pacing pulses delivered to the first chamber that capture the second chamber, the amount of pacing pulses meeting a threshold.
[0125] Example 31: A method according to any one of Examples 27 to 30, wherein confirming the capture of the tissue of the second chamber includes confirming the capture of the tissue based on the delivery of cardiac pacing to the first chamber before adjusting the delivery of the cardiac pacing.
[0126] Example 32: A method according to Example 31, wherein the time interval includes a first time interval, and wherein confirming the capture of the tissue of the second chamber includes: comparing one or more second time intervals from the delivery of cardiac pacing to the first chamber to the sensing of a signal in the second chamber with a second threshold time interval, wherein the second threshold time interval is shorter than the threshold time interval; and determining that a threshold number of the one or more second time intervals is shorter than the second threshold time interval.
[0127] Embodiment 33: The method of any one of Embodiments 26 to 32, wherein the second chamber is a ventricle.
[0128] Embodiment 34: The method of any one of Embodiments 26 to 33, wherein the first chamber is the atrium.
[0129] Example 35: The method of any one of Examples 26 to 34, wherein adjusting the cardiac pacing to the first chamber comprises adjusting the delivery of the cardiac pacing by the device.
[0130] Example 36: The method of Example 35, wherein adjusting the delivery of the cardiac pacing includes disabling the delivery of the cardiac pacing to the first chamber in response to the identification of the capture of the tissue of the second chamber.
[0131] Example 37: The method of Example 36, wherein adjusting the delivery to the heart further comprises re-enabling delivery of cardiac pacing to the first chamber in response to at least one expiration of a time period or a user command.
[0132] Example 38: A method according to any one of Examples 35 to 37, wherein adjusting the delivery of the heart also includes switching the device from a dual-chamber pacing mode to a single-chamber pacing mode in response to the identification of the capture of the tissue of the second chamber.
[0133] Example 39: The method of any one of Examples 35 to 38, wherein adjusting the delivery of the cardiac pacing further comprises maintaining the device in a dual chamber sensing mode in response to the identification of the capture of the tissue of the second chamber.
[0134] Example 40: The device of any one of Examples 26 to 34, wherein adjusting the cardiac pacing to the first chamber comprises adjusting, by the device, one or more settings affecting the cardiac pacing.
[0135] Example 41: The method of Example 40, wherein the one or more settings affecting the cardiac pacing include a maximum amplitude of the pacing output for the cardiac pacing.
[0136] Example 42: The method of any one of Examples 26 to 34, wherein adjusting the cardiac pacemaker to the first chamber comprises adjusting, by the device, a pacing output of the cardiac pacemaker.
[0137] Example 43: A method according to Example 42, wherein adjusting the pacing output of the cardiac pacemaker includes reducing the pulse magnitude of the cardiac pacemaker.
[0138] Example 44: The method of any one of Examples 42 and 43, wherein adjusting the pacing output of the cardiac pacemaker comprises reducing a pulse width of the cardiac pacemaker.
[0139] Embodiment 45: The method of any one of Embodiments 26 to 44, further comprising identifying the capture of the tissue by the second chamber in response to a command from a user.
[0140] Embodiment 46: The method of any one of Embodiments 25 to 43, further comprising sending, by the device, a notification to an external device in response to the identification of the capture of the tissue of the second chamber.
[0141] Embodiment 47: A method, the method comprising: delivering a test cardiac pacing pulse from a device via a first electrode of the device to a first chamber of the heart; detecting electrical activities of the first chamber and the second chamber, respectively, by the device and via the first electrode of the device and a second electrode penetrating into tissue of a second chamber of the heart separated from the first chamber of the heart; determining, by the device and based on the sensed electrical activity of the first chamber, a capture threshold of the tissue of the first chamber; determining, by the device and based on the sensed electrical activity of the second chamber, a cross-chamber capture threshold of the tissue of the second chamber and a maximum pacing output for the first chamber; and based on a comparison of the capture threshold with the maximum pacing output, transmitting, by the device via a network to another device, an indication of adjusting the position of the first electrode within the first chamber.
[0142] Example 48: A method according to Example 47, wherein the maximum pacing output includes maximum cardiac pacing delivered by the device to the first chamber without capturing the tissue of the second chamber, and wherein the method further includes: determining that there is a difference less than a threshold between the atrial capture threshold and the maximum pacing output; and transmitting the indication based on the determination.
[0143] Example 49: A method according to any one of Examples 47 and 48, wherein the cross-chamber capture threshold of the tissue of the second chamber includes a minimum cardiac pace delivered by the device to the first chamber to capture the tissue of the second chamber, and wherein determining the maximum pacing output includes determining the maximum pacing output by the device based on the cross-chamber capture threshold.
[0144] Embodiment 50: A method according to any one of embodiments 47 to 49, wherein the second chamber is a ventricle.
[0145] Embodiment 51: The method of any one of Embodiments 47 to 50, wherein the first chamber is the atrium.
[0146] Embodiment 52: A method according to any one of Embodiments 47 to 51, wherein the instruction to adjust the position of the first electrode includes an instruction to reposition the first electrode from a first position within the first chamber to a second position within the first chamber.
[0147] Embodiment 53: A computer-readable storage medium comprising instructions, which, when executed, cause a processing circuit within a device to perform a method according to any one of claims 26 to 46.
[0148] Embodiment 54: A computer-readable storage medium comprising instructions, which, when executed, cause a processing circuit within a device to perform a method according to any one of Embodiments 47 to 52.
Claims
1. A device, comprising: shell; a first electrode and a second electrode, wherein the first electrode is configured to contact tissue of a first chamber of the heart, and wherein the second electrode is configured to penetrate into tissue of a second chamber of the heart separate from the first chamber of the heart; a sensing circuit within the housing, wherein the sensing circuit is configured to sense electrical activity of the first chamber via the first electrode and to sense electrical activity of the second chamber via the second electrode; a therapy delivery circuit within the housing, wherein the therapy delivery circuit is configured to deliver cardiac pacing to the first chamber via the first electrode and to deliver cardiac pacing to the second chamber via the second electrode; and a processing circuit within the housing, wherein the processing circuit is configured to: identifying capture of the tissue of the second chamber in response to delivery of cardiac pacing to the first chamber by the therapy delivery circuit via the first electrode based on the sensed electrical activity of the second chamber; and The cardiac pacing to the first chamber is adjusted based on the identification of the capture by the second chamber.
2. The apparatus of claim 1 , wherein to identify the capture of the tissue of the second chamber in response to delivery of cardiac pacing to the first chamber by the therapy delivery circuitry via the first electrode, the processing circuitry is configured to: determining a time interval from when the sensing circuit senses a signal via the second electrode; comparing the time interval to a threshold time interval; and The capture is identified based on the comparison.
3. The apparatus of claim 2, wherein the time interval comprises a time interval from the delivery of the cardiac pacing via the first electrode to the signal sensed via the second electrode. 4 . The apparatus of claim 2 , wherein the processing circuit is configured to determine the threshold time interval using one or more previously recorded time intervals.
5. An apparatus according to any one of claims 2 to 4, wherein the processing circuit is configured to identify the capture of the tissue of the second chamber based on the delivery of cardiac pacing to the first chamber by identifying that an amount of pacing pulses delivered to the first chamber that capture the second chamber meets a threshold.
6. The apparatus of any one of claims 2 to 5, wherein the processing circuit is configured to confirm the capture of the tissue of the second chamber based on the delivery of cardiac pacing to the first chamber before adjusting the delivery of cardiac pacing.
7. The device according to any one of claims 1 to 6, wherein the second chamber is a ventricle.
8. The device of any one of claims 1 to 7, wherein the first chamber is an atrium.
9. The device of any one of claims 1 to 8, wherein in order to adjust the cardiac pacing to the first chamber, the processing circuit is configured to adjust the delivery of the cardiac pacing.
10. The apparatus of claim 9, wherein the processing circuit is configured to adjust the delivery of the cardiac pace by disabling delivery of the cardiac pace to the first chamber in response to the identification of the capture of the tissue of the second chamber.
11. The apparatus of claim 10, wherein the processing circuit is further configured to re-enable the delivery of the cardiac pacing to the first chamber in response to at least one expiration of a time period or a user command.
12. A device according to any one of claims 9 to 11, wherein the processing circuit is further configured to adjust the delivery of the cardiac pacing by switching the device from a dual-chamber pacing mode to a single-chamber pacing mode in response to the identification of the capture of the tissue of the second chamber.
13. A device according to any one of claims 9 to 12, wherein the processing circuit is configured to adjust the delivery of the cardiac pacing by maintaining the device in a dual-chamber sensing mode in response to the identification of the capture of the tissue of the second chamber.
14. The apparatus of any one of claims 1 to 8, wherein to adjust the cardiac pacing to the first chamber, the processing circuit is configured to adjust one or more settings affecting the cardiac pacing.
15. The device of any one of claims 1 to 14, wherein the device is fully implantable within the first chamber of the heart.
